ClassID:

95252

C07D403/12 - page 13 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#3601
20160107995
2016-04-21

Histone demethylase inhibitors

#3602
20160107991
2016-04-21

Processes and intermediates for preparing indole pharmaceuticals

#3603
20160106102
2016-04-21

KNOWN AND NEW HETEROCYCLIC COMPOUNDS AS PEST CONTROL AGENTS

#3604
20160102084
2016-04-14

Compositions and methods for inhibition of the JAK pathway

#3605
20160102083
2016-04-14

Enhancer of zeste homolog 2 inhibitors

#3606
20160102054
2016-04-14

Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)

#3607
20160096827
2016-04-07

Tank-binding kinase inhibitor compounds

#3608
20160096824
2016-04-07

Heterocyclic compounds useful for kinase inhibition

#3609
20160096804
2016-04-07

Histone deacetylase inhibitors

#3610
20160096800
2016-04-07

Modulators of the eIF2alpha pathway

#3611
20160090376
2016-03-31

Pyrazine derivatives with extended conjugation and methods of using the same in optical applications

#3612
20160090375
2016-03-31

Substituted phenylazole derivative

#3613
20160090364
2016-03-31

PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS

#3614
20160083370
2016-03-24

Substituted heteroaryl compounds and methods of use thereof

#3615
20160083365
2016-03-24

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

#3616
20160083357
2016-03-24

NOVEL TETRAZOLONE DERIVATIVES

#3617
20160083354
2016-03-24

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#3618
20160082102
2016-03-24

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

#3619
20160082008
2016-03-24

ERK inhibitors and uses thereof

#3620
20160081982
2016-03-24

Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

#3621
20160081340
2016-03-24

Tetrazolinone compound and application of same

#3622
20160081339
2016-03-24

Tetrazolinone compound and use of same

#3623
20160081338
2016-03-24

PLANT GROWTH ACCELERATOR

#3624
20160075727
2016-03-17

Compounds and compositions as kinase inhibitors

#3625
20160075710
2016-03-17

Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors

#3626
20160075691
2016-03-17

4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

#3627
20160075684
2016-03-17

α7 nicotinic acetylcholine receptor modulators and uses thereof-III

#3628
20160075666
2016-03-17

Quinazolinone derivatives useful as FGFR kinase modulators

#3629
20160075662
2016-03-17

Indazolyl- and indolyl-benzamide derivatives

#3630
20160075660
2016-03-17

Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

#3631
20160074541
2016-03-17

Prosthetic compounds for labeling internalizing biomolecules

#3632
20160074381
2016-03-17

Modulators of cellular adhesion

#3633
20160074361
2016-03-17

Pro-neurogenic compounds

#3634
20160068546
2016-03-10

Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

#3635
20160068541
2016-03-10

Analgesic compounds and methods of use

#3636
20160068512
2016-03-10

Quinazoline derivatives useful as CB-1 inverse agonists

#3637
20160068494
2016-03-10

Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases

#3638
20160068493
2016-03-10

SUBSTITUTED PYRIDAZINE CARBOXIMIDE COMPOUNDS

#3639
20160068482
2016-03-10

Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors

#3640
20160067350
2016-03-10

Drug-conjugates, conjugation methods, and uses thereof

#3641
20160067302
2016-03-10

Hepatitis C virus inhibitors

#3642
20160067257
2016-03-10

SCREENING METHOD AND COMPOUNDS FOR MODULATING TELOMERASE ACTIVITY

#3643
20160067224
2016-03-10

Therapeutic compounds

#3644
20160060260
2016-03-03

BROMODOMAIN INHIBITORS FOR TREATING DISEASE

#3645
20160060247
2016-03-03

Histone demethylase inhibitors

#3646
20160060231
2016-03-03

SUBSTITUTED BICYCLIC DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY

#3647
20160060230
2016-03-03

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

#3648
20160060226
2016-03-03

Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase

#3649
20160060224
2016-03-03

N-myristoyl transferase inhibitors

#3650
20160052926
2016-02-25

NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND USAGE THEREOF

#3651
20160052914
2016-02-25

Compounds and methods for myotonic dystrophy therapy

#3652
20160052896
2016-02-25

Isoxazole analogs as mediators of transcriptional induction of E-cadherin

#3653
20160052890
2016-02-25

Compounds useful as antibiotic tolerance inhibitors

#3654
20160051550
2016-02-25

Combinations of AKT inhibitor compounds and erlotinib, and methods of use

#3655
20160051512
2016-02-25

N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

#3656
20160050927
2016-02-25

Pesticidal pyrazole compounds

#3657
20160050925
2016-02-25

Fungicidal amides

#3658
20160046643
2016-02-18

Highly efficient polarizing agents for dynamic nuclear polarization

#3659
20160046632
2016-02-18

Octahydropyrrolopyrroles their preparation and use

#3660
20160046626
2016-02-18

Bicyclic sulfonamide compounds as sodium channel inhibitors

#3661
20160046612
2016-02-18

Heterocyclic derivative and pharmaceutical drug

#3662
20160046602
2016-02-18

Inhibitors of c-fms kinase

#3663
20160046574
2016-02-18

Serotonin receptor modulators

#3664
20160045477
2016-02-18

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#3665
20160039838
2016-02-11

Aminoquinazoline derivatives and their salts and methods of use thereof

#3666
20160039834
2016-02-11

CARM1 inhibitors and uses thereof

#3667
20160039798
2016-02-11

N-(2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-5-yl)-4-quinazolinamine and N-(2,3-dihydro-1H-indol-5-yl)-4-quinazolinamine derivatives as perk inhibitors

#3668
20160039797
2016-02-11

Kinase inhibitors based upon N-alkyl pyrazoles

#3669
20160039790
2016-02-11

1,2,6-substituted benzimidazoles as flap modulators

#3670
20160039773
2016-02-11

Fumarate analogs and uses thereof

#3671
20160039771
2016-02-11

Dihydroxy aromatic heterocyclic compound

#3672
20160039769
2016-02-11

Pyrazolyl guanidine FF-ATPase inhibitors and therapeutic uses thereof

#3673
20160039766
2016-02-11

Cannabinoid receptor mediating compounds

#3674
20160039755
2016-02-11

Oxindole compounds, solvent-free synthesis and use thereof

#3675
20160038504
2016-02-11

Biaryl amide compounds as kinase inhibitors

#3676
20160038476
2016-02-11

Nonsteroidal and steroidal compounds with potent androgen receptor down-regulation and anti prostate cancer activity

#3677
20160031890
2016-02-04

Methods, compounds, and compositions for inhibition of ROS

#3678
20160031880
2016-02-04

NAMPT and ROCK inhibitors

#3679
20160031873
2016-02-04

Carboxamide derivatives and use thereof

#3680
20160031858
2016-02-04

DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES

#3681
20160031835
2016-02-04

Substituted 1,2,4-triazines as tubulin inhibitors

#3682
20160031828
2016-02-04

Antimicrobial compounds and methods of making and using the same

#3683
20160031813
2016-02-04

Nampt Inhibitors

#3684
20160030431
2016-02-04

Compositions and methods for treating Alzheimer's disease

#3685
20160030428
2016-02-04

Pyrimidinedione compounds

#3686
20160024072
2016-01-28

Heterocyclic ring and carbocyclic derivative

#3687
20160024055
2016-01-28

Dimeric compounds

#3688
20160024054
2016-01-28

Phosphatidylinositol 3-kinase inhibitors

#3689
20160024050
2016-01-28

Acrylamide derivatives as antimalarial agents

#3690
20160024049
2016-01-28

Heterocyclic compound

#3691
20160024022
2016-01-28

Pyrimidines as sodium channel blockers

#3692
20160024021
2016-01-28

Pyrimidine and pyridine compounds and their usage

#3693
20160024020
2016-01-28

Intermediates to prepare herbicidal pyrimidone derivatives

#3694
20160024017
2016-01-28

Arginine methyltransferase inhibitors and uses thereof

#3695
20160024007
2016-01-28

Octahydrocyclopentapyrroles, their preparation and use

#3696
20160022670
2016-01-28

Benzamides

#3697
20160022640
2016-01-28

Pyrazole derivatives and their uses thereof

#3698
20160021883
2016-01-28

Molecules having certain pesticidal utilities, intermediates, compositions, and processes, related thereto

#3699
20160016947
2016-01-21

Substituted pyridizinone derivatives as PDE10 inhibitors

#3700
20160016940
2016-01-21

Indole and indazole compounds that activate AMPK

#3701
20160016939
2016-01-21

Heterocyclic inhibitors of the sodium channel

#3702
20160016934
2016-01-21

KINASE INHIBITORS

#3703
20160016929
2016-01-21

PRO-DRUG COMPOUNDS

#3704
20160016916
2016-01-21

Exo Olefin-Containing Nuclear Transport Modulators and Uses Thereof

#3705
20160016914
2016-01-21

Spirocycloheptanes as inhibitors of rock

#3706
20160016910
2016-01-21

Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

#3707
20160015713
2016-01-21

Modulators of toll-like receptors

#3708
20160009760
2016-01-14

Ligands for antibody and Fc-fusion protein purification by affinity chromotography IV

#3709
20160009735
2016-01-14

Glucokinase Activators

#3710
20160009703
2016-01-14

Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof

#3711
20160009695
2016-01-14

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors

#3712
20160009694
2016-01-14

CYCLOHEXANEDIAMINE COMPOUNDS AND METHODS FOR THEIR PREPARATION

#3713
20160009693
2016-01-14

HERBICIDAL COMPOUNDS

#3714
20160009686
2016-01-14

VEGFR3 INHIBITORS

#3715
20160009666
2016-01-14

Antiviral compounds

#3716
20160009664
2016-01-14

Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase IX

#3717
20160009663
2016-01-14

Substituted quinoxalines as B-raf kinase inhibitors

#3718
20160009661
2016-01-14

2,4-pyrimidinediamine compounds and their uses

#3719
20160009660
2016-01-14

2,4-pyrimidinediamine compounds and their uses

#3720
20160009659
2016-01-14

Pyrimidine carboxamides as sodium channel blockers

#3721
20160008326
2016-01-14

Bicyclic compound, production and use thereof

#3722
20160002251
2016-01-07

Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the same

#3723
20160002222
2016-01-07

PRODRUG FORMS OF KINASE INHIBITORS AND THEIR USE IN THERAPY

#3724
20160002210
2016-01-07

Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof

#3725
20160002176
2016-01-07

ERK inhibitors and uses thereof

#3726
20160002175
2016-01-07

Pyrimidine-2,4-diamine derivatives for treatment of cancer

#3727
20160002172
2016-01-07

Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

#3728
20160000927
2016-01-07

Reversible pegylated drugs

#3729
20160000781
2016-01-07

Phthalazinone derivatives

#3730
20160000760
2016-01-07

Antiviral compounds

#3731
20150376212
2015-12-31

Flap modulators

#3732
20150376173
2015-12-31

Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent

#3733
20150376165
2015-12-31

Antiviral compounds

#3734
20150376141
2015-12-31

NEW COMPOUNDS

#3735
20150376139
2015-12-31

Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

#3736
20150376133
2015-12-31

C-Met Modulators and Methods of Use

#3737
20150374693
2015-12-31

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

#3738
20150373980
2015-12-31

Fungicidal pyrimidine compounds

#3739
20150368295
2015-12-24

Method for producing pyrazoles, novel pyrazoles and applications thereof

#3740
20150368270
2015-12-24

FLAP modulators

#3741
20150368228
2015-12-24

Antiviral compounds

#3742
20150368205
2015-12-24

Poly (ADP-ribose) polymerase inhibitor

#3743
20150366990
2015-12-24

Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same

#3744
20150361099
2015-12-17

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#3745
20150361095
2015-12-17

Phosphatidylinositol 3-kinase inhibitors

#3746
20150361069
2015-12-17

Quinazolines as kinase inhibitors

#3747
20150361068
2015-12-17

Phosphatidylinositol 3-kinase inhibitors

#3748
20150361055
2015-12-17

Sulfoximine substituted quinazolines for pharmaceutical compositions

#3749
20150361052
2015-12-17

Pyrimidinone carboxamide inhibitors of endothelial lipase

#3750
20150361042
2015-12-17

PRMT5 inhibitors and uses thereof

#3751
20150359904
2015-12-17

Conjugates comprising cell-binding agents and cytotoxic agents

#3752
20150353559
2015-12-10

NEW BICYCLIC DERIVATIVES

#3753
20150353549
2015-12-10

Inhibitors of histone deacetylase

#3754
20150353533
2015-12-10

Heterocyclic amides as kinase inhibitors

#3755
20150353528
2015-12-10

OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

#3756
20150353527
2015-12-10

Non-selective kinase inhibitors

#3757
20150353512
2015-12-10

Triazine carboxamides as sodium channel blockers

#3758
20150353505
2015-12-10

Phthalazinones and isoquinolinones as rock inhibitors

#3759
20150353499
2015-12-10

Antiproliferative benzo [B] azepin-2-ones

#3760
20150352111
2015-12-10

Therapeutic Indications of Kinase Inhibitors

#3761
20150352106
2015-12-10

Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine

#3762
20150344464
2015-12-03

Rho-kinase inhibitors and method of preparation

#3763
20150344461
2015-12-03

Hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds

#3764
20150344444
2015-12-03

BET-PROTEIN-INHIBITING DIHYDROXYQUINOXALINONES

#3765
20150344443
2015-12-03

Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

#3766
20150344436
2015-12-03

PKM2 modulators and methods for their use

#3767
20150344430
2015-12-03

METHODS OF LOWERING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

#3768
20150344426
2015-12-03

COMPOUNDS AND THERAPEUTIC USES THEREOF

#3769
20150344425
2015-12-03

Indole carboxamide derivatives as P2Xreceptor antagonists

#3770
20150344423
2015-12-03

Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ

#3771
20150340627
2015-11-26

MATERIALS FOR ELECTRONIC DEVICES

#3772
20150338563
2015-11-26

Resin composition

#3773
20150336975
2015-11-26

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

#3774
20150336967
2015-11-26

Benzimidazole derivatives as Kinase Inhibitors

#3775
20150336945
2015-11-26

Substituted quinolines as modulators of sodium channels

#3776
20150336925
2015-11-26

Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors

#3777
20150336905
2015-11-26

Substituted [1,2,4]triazole compounds and their use as fungicides

#3778
20150336903
2015-11-26

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

#3779
20150336901
2015-11-26

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#3780
20150336876
2015-11-26

Phenoxyalkylamine compound

#3781
20150335702
2015-11-26

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

#3782
20150335618
2015-11-26

Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders

#3783
20150329558
2015-11-19

Fused heterocyclic compounds as ion channel modulators

#3784
20150329549
2015-11-19

Carboxamide derivatives

#3785
20150329537
2015-11-19

CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA

#3786
20150329532
2015-11-19

2,4-pyrimidinediamine compounds and their uses

#3787
20150329526
2015-11-19

Process for the preparation of pazopanib or salts thereof

#3788
20150329523
2015-11-19

Kinase inhibitors

#3789
20150329498
2015-11-19

IRAK INHIBITORS AND USES THEREOF

#3790
20150329497
2015-11-19

Small molecule agonists of neurotensin receptor 1

#3791
20150329493
2015-11-19

OMEGA-AMINO ACID DERIVATIVES OF BENZENE, PYRIDINE, AND PYRIDAZINE COMPOUNDS

#3792
20150328223
2015-11-19

4,6-disubstituted pyrimidines as kinase inhibitors

#3793
20150322060
2015-11-12

Pyrrolidine derivatives and their use as complement pathway modulators

#3794
20150322046
2015-11-12

Methods for treatment of breast cancer nonresponsive to trastuzumab

#3795
20150322038
2015-11-12

PYRAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

#3796
20150322020
2015-11-12

Squaric derivatives for the treatment of hepatitis C

#3797
20150322008
2015-11-12

Indole carboxamide derivatives as P2X7 receptor antagonist

#3798
20150320757
2015-11-12

Guanidine derivatives for the treatment of hepatitis C

#3799
20150320751
2015-11-12

Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor

#3800
20150315209
2015-11-05

Heterocyclic compounds having cholesterol 24-hydroxylase activity

#3801
20150315182
2015-11-05

Substituted reverse pyrimidine Bmi-1 inhibitors

#3802
20150315176
2015-11-05

Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1H-pyrazol-3-ylamine

#3803
20150313232
2015-11-05

1,2,4-triazine-3,5-dione-6-carboxamides and use thereof as herbicide

#3804
20150307534
2015-10-29

Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide

#3805
20150307515
2015-10-29

Compositions and methods for inhibition of the JAK pathway

#3806
20150307494
2015-10-29

Substituted 1,7-naphthyridines as dopamine D1 ligands

#3807
20150307478
2015-10-29

Compounds useful for treating AIDS

#3808
20150307475
2015-10-29

Autotaxin inhibitors

#3809
20150307465
2015-10-29

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use

#3810
20150307461
2015-10-29

ANTIVIRAL COMPOUNDS

#3811
20150306095
2015-10-29

Indolinone derivative as tyrosine kinase inhibitor

#3812
20150306089
2015-10-29

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

#3813
20150299191
2015-10-22

Compounds and methods for inhibiting fascin

#3814
20150299189
2015-10-22

Amine derivative or salt thereof

#3815
20150299183
2015-10-22

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses

#3816
20150299163
2015-10-22

Compounds for use in the treatment of parasitic diseases

#3817
20150299146
2015-10-22

Tetrazolinone compound and applications thereof

#3818
20150299134
2015-10-22

Methods of treating cancer with a pyrazole derivative

#3819
20150299133
2015-10-22

Neurotensin receptor ligands

#3820
20150299129
2015-10-22

Compounds for treating cancer

#3821
20150299121
2015-10-22

Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseases

#3822
20150297595
2015-10-22

Inhibitors of syk and JAK protein kinases

#3823
20150297586
2015-10-22

Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives

#3824
20150296787
2015-10-22

Substituted azines as pesticides

#3825
20150291588
2015-10-15

Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer

#3826
20150291565
2015-10-15

INDOLE COMPOUNDS AND THEIR USE AS ANTIMICROBIALS

#3827
20150291564
2015-10-15

Substituted indol-5-ol derivatives and their therapeutical applications

#3828
20150291533
2015-10-15

Benzoazepine derivative and medical use thereof

#3829
20150290195
2015-10-15

Pro-neurogenic compounds

#3830
20150284405
2015-10-08

Bicyclic-fused heteroaryl or aryl compounds

#3831
20150284386
2015-10-08

2-oxo-2,3-dihydro-indoles for the treatment of CNS disorders

#3832
20150284367
2015-10-08

Inhibitors of SYK

#3833
20150284339
2015-10-08

Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

#3834
20150283117
2015-10-08

Triazolone compounds as mPGES-1 inhibitors

#3835
20150280138
2015-10-01

Thermally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same

#3836
20150274713
2015-10-01

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#3837
20150274711
2015-10-01

Antiviral compounds

#3838
20150274709
2015-10-01

Substituted quinoxalines as kinase inhibitors

#3839
20150274705
2015-10-01

Substituted heteroaryl compounds and methods of use

#3840
20150274704
2015-10-01

Substituted heteroaryl compounds and methods of use

#3841
20150274703
2015-10-01

1H-Indole-3-Carboxamide Derivatives And Use Thereof As P2Y12 Antagonists

#3842
20150274702
2015-10-01

Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases

#3843
20150274701
2015-10-01

NEW AZIDES, METHOD FOR PRODUCING SAME AND APPLICATIONS THEREOF

#3844
20150274698
2015-10-01

Hydrazide containing nuclear transport modulators and uses thereof

#3845
20150274660
2015-10-01

Inhibitors of histone methyltransferase G9a

#3846
20150274658
2015-10-01

THERAPEUTIC LACTAMS

#3847
20150266893
2015-09-24

Fused ring analogues of anti-fibrotic agents

#3848
20150266862
2015-09-24

Heterocyclic compounds as NaV channel inhibitors and uses thereof

#3849
20150266861
2015-09-24

Glucagon Receptor Modulators

#3850
20150266859
2015-09-24

Glucagon receptor modulators

#3851
20150266828
2015-09-24

2,4-pyrimidinediamine compounds and their uses

#3852
20150266824
2015-09-24

Pyrazole amide derivative

#3853
20150266822
2015-09-24

Amide Compounds, Compositions And Uses Thereof

#3854
20150259363
2015-09-17

Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity

#3855
20150259357
2015-09-17

FLAP modulators

#3856
20150259344
2015-09-17

IMIDAZOLE DERIVATIVE

#3857
20150259339
2015-09-17

Substituted pyrido[3,2-d]pyrimidines for treating cancer

#3858
20150259329
2015-09-17

NOVEL HETEROCYCLE COMPOUNDS AND USES THEREOF

#3859
20150259328
2015-09-17

Substituted pyrimidinyl kinase inhibitors

#3860
20150259297
2015-09-17

Five-membered heterocycles useful as serine protease inhibitors

#3861
20150259296
2015-09-17

Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin

#3862
20150259293
2015-09-17

Pyridine compounds and the uses thereof

#3863
20150259286
2015-09-17

7-hydroxy-indolinyl antagonists of P2Yreceptor

#3864
20150259282
2015-09-17

Potassium channel blockers

#3865
20150258100
2015-09-17

Antibacterial protein kinase inhibitors

#3866
20150257385
2015-09-17

Substituted pyrimidine compound and uses thereof

#3867
20150252043
2015-09-10

Hematopoietic growth factor mimetic small molecule compounds and their uses

#3868
20150252038
2015-09-10

Substituted benzamides and methods of use thereof

#3869
20150252030
2015-09-10

N-acylhydrazone derivatives for selective T cell inhibitor and anti-lymphoid malignancy drug

#3870
20150252025
2015-09-10

Rho kinase inhibitors

#3871
20150252024
2015-09-10

1-pyrazolyl-3-((4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors

#3872
20150252021
2015-09-10

Asymmetric piperidinyl-substituted ureas as medicines

#3873
20150252008
2015-09-10

Flap modulators

#3874
20150246917
2015-09-03

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

#3875
20150246893
2015-09-03

Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions

#3876
20150246890
2015-09-03

Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith

#3877
20150245614
2015-09-03

PLANT GROWTH ACCELERATOR

#3878
20150239943
2015-08-27

Compounds for treating papilloma virus infection

#3879
20150239921
2015-08-27

Phosphonate compounds for treatment of complement mediated disorders

#3880
20150239920
2015-08-27

Ether compounds for treatment of complement mediated disorders

#3881
20150239919
2015-08-27

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders

#3882
20150239895
2015-08-27

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

#3883
20150239894
2015-08-27

Amino compounds for treatment of complement mediated disorders

#3884
20150239893
2015-08-27

Amide compounds for treatment of complement mediated disorders

#3885
20150239871
2015-08-27

Process for the preparation of vilazodone hydrochloride and its amorphous form

#3886
20150239868
2015-08-27

Alkyne compounds for treatment of complement mediated disorders

#3887
20150239866
2015-08-27

Triazolyl derivatives as Syk inhibitors

#3888
20150239851
2015-08-27

Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds

#3889
20150239847
2015-08-27

Heterocyclic compounds as pesticides

#3890
20150239838
2015-08-27

Compounds for treatment of complement mediated disorders

#3891
20150239837
2015-08-27

Factor D inhibitors useful for treating inflammatory disorders

#3892
20150238641
2015-08-27

Compositions targeting bradykinin receptor B1 for medical imaging of cancer and other disorders

#3893
20150232470
2015-08-20

Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors

#3894
20150232466
2015-08-20

Heterocyclic acrylamides and their use as pharmaceuticals

#3895
20150232460
2015-08-20

Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists

#3896
20150232435
2015-08-20

Urea and amide derivatives of aminoalkylpiperazines and use thereof

#3897
20150232429
2015-08-20

SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS

#3898
20150232428
2015-08-20

Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors

#3899
20150225423
2015-08-13

Pyrimidines as novel therapeutic agents

#3900
20150225410
2015-08-13

Heterocyclic compounds and uses thereof